Pediatrix Medical Group (NYSE:MD) Sees Large Volume Increase

Pediatrix Medical Group, Inc. (NYSE:MDGet Free Report) shares saw unusually-high trading volume on Thursday . Approximately 531,784 shares traded hands during mid-day trading, a decline of 28% from the previous session’s volume of 743,516 shares.The stock last traded at $7.56 and had previously closed at $7.26.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on MD. Mizuho lowered their price target on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a report on Wednesday, February 21st. Truist Financial reissued a “hold” rating and set a $10.00 price target on shares of Pediatrix Medical Group in a report on Wednesday, May 15th. Jefferies Financial Group lowered their price target on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, March 6th. Finally, TheStreet lowered Pediatrix Medical Group from a “c” rating to a “d” rating in a research report on Friday, February 23rd. Five analysts have rated the stock with a hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $9.38.

View Our Latest Stock Report on MD

Pediatrix Medical Group Price Performance

The business has a 50-day simple moving average of $8.82 and a 200 day simple moving average of $9.08. The stock has a market cap of $644.59 million, a P/E ratio of -9.01, a price-to-earnings-growth ratio of 1.39 and a beta of 1.58. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.81.

Pediatrix Medical Group (NYSE:MDGet Free Report) last announced its earnings results on Tuesday, May 7th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.15 by $0.02. Pediatrix Medical Group had a positive return on equity of 10.31% and a negative net margin of 3.53%. The company had revenue of $495.10 million for the quarter, compared to analyst estimates of $496.25 million. On average, analysts forecast that Pediatrix Medical Group, Inc. will post 1.12 earnings per share for the current year.

Institutional Trading of Pediatrix Medical Group

Several institutional investors and hedge funds have recently modified their holdings of MD. Performa Ltd US LLC grew its holdings in shares of Pediatrix Medical Group by 130.8% in the fourth quarter. Performa Ltd US LLC now owns 3,000 shares of the company’s stock valued at $28,000 after acquiring an additional 1,700 shares in the last quarter. Counterpoint Mutual Funds LLC boosted its holdings in shares of Pediatrix Medical Group by 53.4% in the fourth quarter. Counterpoint Mutual Funds LLC now owns 10,140 shares of the company’s stock worth $94,000 after acquiring an additional 3,528 shares during the period. Virtu Financial LLC bought a new position in shares of Pediatrix Medical Group in the first quarter worth $124,000. AXQ Capital LP bought a new position in shares of Pediatrix Medical Group in the third quarter worth $135,000. Finally, Jump Financial LLC bought a new position in shares of Pediatrix Medical Group in the fourth quarter worth $154,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Company Profile

(Get Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

See Also

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.